
Obesity and Use of GLP-1 Drugs are Increasing in People with Type 1 Diabetes
The use of GLP-1 receptor agonists rose in patients who have type 1 diabetes as obesity rates increased for these patients, according to a new study published online in Diabetes, Obesity and Metabolism. In the highest obesity category assessed by …